The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort study
Open accessAbstract
BACKGROUND: Uncertainty remains concerning the association of blood cholesterol with the risk of subsequent dementia. Using data from people with lipid measurements in the UK Clinical Practice Research Datalink (CPRD), we examined the association between blood lipid levels and dementia (both vascular and non-vascular, including Alzheimer's disease) by age at first measurement of blood lipids and duration of follow-up. METHODS: We studied a cohort from the UK CPRD of people aged 40 years or older with a first total cholesterol recording between Jan 1, 1992, and Dec 31, 2009. Follow-up was until the first record of dementia, the last data collection date, patient death or transfer out of the practice, or Jan 5, 2015, whichever was earliest. We excluded individuals with a record of dementia before the total cholesterol measurement. We used Poisson regression to examine the association between baseline total cholesterol, LDL cholesterol and HDL cholesterol, and triglycerides and incident dementia diagnosis. Analyses were stratified by age at first measurement (<65 years or ≥65 years) and duration of follow-up (<10 years or ≥10 years). Our primary focus was LDL cholesterol. We adjusted for age, sex, calendar year, country within the UK, socioeconomic status, ethnicity, smoking, alcohol, body-mass index, comorbidities, and prescriptions. FINDINGS: 1 853 954 people had a first total cholesterol recording (dementia diagnosis in 49 416 [2·7%] people), including 953 635 [51·4%] people with LDL cholesterol values for analysis (dementia diagnosis in 21 602 [2·3%] people). Overall, we found a modest positive association between LDL cholesterol and dementia, with an adjusted rate ratio (RR) of 1·05 (95% CI 1·03-1·06) per SD increase in LDL cholesterol (1·01 mmol/L or 39 mg/dL increase). Adjusted RRs per 1-SD increase in LDL cholesterol in people younger than 65 years at baseline (n=636 262) were 1·10 (95% 1·04-1·15) for dementia diagnosed in the first 10 years after measurement and 1·17 (1·08-1·27) for dementia diagnosed more than 10 years after measurement. Associations for LDL cholesterol in people aged 65 years or older at baseline (n=317 373) were weaker compared with people younger than 65 years (RR 1·03 [95% CI 1·01-1·05] for dementia diagnosed during the first 10 years of follow-up and 1·07 [1·03-1·13] for dementia diagnosed after 10 years). We observed a weaker association between total cholesterol and dementia incidence and no consistent associations for HDL cholesterol and triglycerides. INTERPRETATION: LDL cholesterol measured in mid-life (<65 years) is modestly associated with dementia risk more than 10 years later. LDL cholesterol should be added to the list of modifiable risk factors for dementia. FUNDING: The Alzheimer's Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher baseline LDL-C in a large cohort from UK general practice cohort (n=1,853,954) followed up for a median of 7.4 years, was similarly associated with higher risk of all cause dementia (RR 1.05, 1.03 -1.06 per SD increase in LDLC, 1.01 mmol/L or 39 mg/dL increase). (154)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This risk was greater in midlife, people aged <65 with high LDL-C had increased risk for dementia diagnosed within 10 years (RR 1·10, 1·04 -1·15) and over 10 years after baseline (RR 1·17, 1·08 -1·27).”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedFriedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Rockwood, K., Kirkland, S., Hogan, D. B., MacKnight, C., Merry, H., Verreault, R., Wolfson, C., & McDowell, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.223 · Cited by 516
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
BMI and risk of dementia in two million people over two decades: a retrospective cohort study
Qizilbash, N., Gregson, J., Johnson, M. E., Pearce, N., Douglas, I., Wing, K., Evans, S. J. W., & Pocock, S. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00033-9 · Cited by 475
Self-citation
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Vascular dementia: From pathobiology to emerging perspectives
Morgan, A. E., & Auley, M. T. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102278 · Cited by 114
Brain, J., Greene, L., Tang, E. Y. H., Louise, J., Salter, A. B., Beach, S., Turnbull, D. A., Siervo, M., Stephan, B. C. M., & Tully, P. J. (2023) · Frontiers in Epidemiology · doi:10.3389/fepid.2023.1095236 · Cited by 100
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101695 · Cited by 88
Tooth loss and the risk of cognitive decline and dementia: A meta-analysis of cohort studies
Li, L., Zhang, Q., Yang, D., Yang, S., Zhao, Y., Jiang, M., Wang, X., Zhao, L., Liu, Q., Lu, Z., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1103052 · Cited by 85
“Some studies suggested a follow-up of 10 years (47, 48), so these risk factors in earlier life could be identified, patients in earlier stages of dementia be diagnosed, and reverse causation be minimized, especially in studies, except prospective cohorts.”
Background
Metadata
- Authors
- Iwagami, M., Qizilbash, N., Gregson, J., Douglas, I., Johnson, M., Pearce, N., Evans, S., & Pocock, S.
- Affiliations
- University of Tsukuba (JP)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Qizilbash, Nawab
- ORCID
- Venue
- The Lancet Healthy Longevity
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 2
- Issue
- 8
- Pages
- e498-e506
- ISSN
- 2666-7568 (ISSN-L)
- OpenAlex
- W3184285584
- Cited by
- 161
- References
- 32
- Citations by year
- 2026: 33 · 2025: 36 · 2024: 41 · 2023: 29 · 2022: 20 · 2021: 2
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The Lancet Healthy Longevity (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Alzheimer's Society
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- serum cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, total cholesterol, dementia risk, Alzheimer's disease, vascular dementia, follow-up duration, lipid-lowering therapy, statins, fibrates, ezetimibe, nicotinic acid, cholesterol absorption inhibitors, Clinical Practice Research Datalink
- MeSH terms
- Alzheimer Disease, Humans, Lipids, Cholesterol, HDL, Cholesterol, LDL, Retrospective Studies, Triglycerides, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort study. https://app.cochat.ai/papers/10.1016/s2666-7568(21)00150-1
- The paper
- Iwagami, M., Qizilbash, N., Gregson, J., Douglas, I., Johnson, M., Pearce, N., Evans, S., & Pocock, S. (2021). Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort study. The Lancet Healthy Longevity. https://doi.org/10.1016/s2666-7568(21)00150-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.